Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Merlini

Showing results (71-80 of 158) with videos related to

Pageof 16
Sort By:
Haematologica|October 1, 1981
Agarose gel electrophoresis in newbornsR Moratti, G Merlini, G L Melzi D'Eril, et al.
Haematologica|September 1, 1985
Alpha heavy chain disease: report of two casesL Geraci, G Merlini, A Spadano, et al.
Clinical Chemistry|March 7, 2000
Procalcitonin is not a reliable marker for the assessment of severity in acute pancreatitis without infectious complicationsG V Melzi D'Eril, G Merlini, S Finazzi, et al.
Haematologica|March 7, 2000
Clotting alterations in primary systemic amyloidosisG Gamba, N Montani, E Anesi, et al.
Haematologica|November 1, 1982
Alpha-2-HS-glycoprotein in multiple myelomaF Pavesi, G Merlini, R Epis, et al.
Clinical Chemistry and Laboratory Medicine|February 8, 2002
Protein aggregationG Merlini, V Bellotti, A Andreola, et al.
Haematologica|September 1, 1995
Diagnostic approach to and follow-up of difficult cases of AL amyloidosisV Perfetti, P Garini, M C Vignarelli, et al.
Archives of Internal Medicine|September 1, 1987
Effects of a new aminodiphosphonate (aminohydroxybutylidene diphosphonate) in patients with osteolytic lesions from metastases and myelomatosis. Comparison with dichloromethylene diphosphonateG Attardo-Parrinello, G Merlini, F Pavesi, et al.
Tumori|December 31, 1985
Peptichemio, vincristine, prednisone induction treatment in multiple myelomaG Merlini, A Riccardi, P G Riccardi, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1984
Plasma cell DNA content in multiple myeloma and related paraproteinemic disorders. Relationship with clinical and cytokinetic featuresC Montecucco, A Riccardi, G Merlini, et al.
Pageof 16

Showing results (71-80 of 158) with videos related to

Sort By:
Pageof 16
Haematologica|October 1, 1981
Agarose gel electrophoresis in newbornsR Moratti, G Merlini, G L Melzi D'Eril, et al.
Haematologica|September 1, 1985
Alpha heavy chain disease: report of two casesL Geraci, G Merlini, A Spadano, et al.
Clinical Chemistry|March 7, 2000
Procalcitonin is not a reliable marker for the assessment of severity in acute pancreatitis without infectious complicationsG V Melzi D'Eril, G Merlini, S Finazzi, et al.
Haematologica|March 7, 2000
Clotting alterations in primary systemic amyloidosisG Gamba, N Montani, E Anesi, et al.
Haematologica|November 1, 1982
Alpha-2-HS-glycoprotein in multiple myelomaF Pavesi, G Merlini, R Epis, et al.
Clinical Chemistry and Laboratory Medicine|February 8, 2002
Protein aggregationG Merlini, V Bellotti, A Andreola, et al.
Haematologica|September 1, 1995
Diagnostic approach to and follow-up of difficult cases of AL amyloidosisV Perfetti, P Garini, M C Vignarelli, et al.
Archives of Internal Medicine|September 1, 1987
Effects of a new aminodiphosphonate (aminohydroxybutylidene diphosphonate) in patients with osteolytic lesions from metastases and myelomatosis. Comparison with dichloromethylene diphosphonateG Attardo-Parrinello, G Merlini, F Pavesi, et al.
Tumori|December 31, 1985
Peptichemio, vincristine, prednisone induction treatment in multiple myelomaG Merlini, A Riccardi, P G Riccardi, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1984
Plasma cell DNA content in multiple myeloma and related paraproteinemic disorders. Relationship with clinical and cytokinetic featuresC Montecucco, A Riccardi, G Merlini, et al.
Pageof 16